Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation

Riccarda Granata, Davide Gallo, Raul M. Luque, Alessandra Baragli, Francesca Scarlatti, Cristina Grande, Iacopo Gesmundo, Jose Córdoba-Chacón, Loredana Bergandi, Fabio Settanni, Gabriele Togliatto, Marco Volante, Stefano Garetto, Marta Annunziata, Belén Chanclón, Eleonora Gargantini, Stefano Rocchietto, Lina Matera, Giacomo Datta, Mario MorinoMaria Felice Brizzi, Huy Ong, Giovanni Camussi, Justo P. Castaño, Mauro Papotti, Ezio Ghigo

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The metabolic actions of the ghrelin gene-derived peptide obestatin are still unclear. We investigated obestatin effects in vitro, on adipocyte function, and in vivo, on insulin resistance and inflammation in mice fed a high-fat diet (HFD). Obestatin effects on apoptosis, differentiation, lipolysis, and glucose uptake were determined in vitro in mouse 3T3-L1 and in human subcutaneous (hSC) and omental (hOM) adipocytes. In vivo, the influence of obestatin on glucose metabolism was assessed in mice fed an HFD for 8 wk. 3T3-L1, hSC, and hOM preadipocytes and adipocytes secreted obestatin and showed specific binding for the hormone. Obestatin prevented apoptosis in 3T3-L1 preadipocytes by increasing phosphoinositide 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK)1/2 signaling. In both mice and human adipocytes, obestatin inhibited isoproterenol-induced lipolysis, promoted AMP-activated protein kinase phosphorylation, induced adiponectin, and reduced leptin secretion. Obestatin also enhanced glucose uptake in either the absence or presence of insulin, promoted GLUT4 translocation, and increased Akt phosphorylation and sirtuin 1 (SIRT1) protein expression. Inhibition of SIRT1 by small interfering RNA reduced obestatin-induced glucose uptake. In HFD-fed mice, obestatin reduced insulin resistance, increased insulin secretion from pancreatic islets, and reduced adipocyte apoptosis and inflammation in metabolic tissues. These results provide evidence of a novel role for obestatin in adipocyte function and glucose metabolism and suggest potential therapeutic perspectives in insulin resistance and metabolic dysfunctions.

Original languageEnglish
Pages (from-to)3393-3411
Number of pages19
JournalFASEB Journal
Volume26
Issue number8
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Ghrelin
Nutrition
Adipocytes
Insulin Resistance
Insulin
Diet
Inflammation
High Fat Diet
Glucose
Sirtuin 1
Lipolysis
Phosphorylation
Apoptosis
Fats
Metabolism
AMP-Activated Protein Kinases
1-Phosphatidylinositol 4-Kinase
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Adiponectin

Keywords

  • Glucose uptake
  • High-fat diet
  • Lipolysis
  • PI3K/Akt and AMP-activated protein kinase
  • Sirtuin 1

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology

Cite this

Granata, R., Gallo, D., Luque, R. M., Baragli, A., Scarlatti, F., Grande, C., ... Ghigo, E. (2012). Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB Journal, 26(8), 3393-3411. https://doi.org/10.1096/fj.11-201343

Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. / Granata, Riccarda; Gallo, Davide; Luque, Raul M.; Baragli, Alessandra; Scarlatti, Francesca; Grande, Cristina; Gesmundo, Iacopo; Córdoba-Chacón, Jose; Bergandi, Loredana; Settanni, Fabio; Togliatto, Gabriele; Volante, Marco; Garetto, Stefano; Annunziata, Marta; Chanclón, Belén; Gargantini, Eleonora; Rocchietto, Stefano; Matera, Lina; Datta, Giacomo; Morino, Mario; Brizzi, Maria Felice; Ong, Huy; Camussi, Giovanni; Castaño, Justo P.; Papotti, Mauro; Ghigo, Ezio.

In: FASEB Journal, Vol. 26, No. 8, 08.2012, p. 3393-3411.

Research output: Contribution to journalArticle

Granata, R, Gallo, D, Luque, RM, Baragli, A, Scarlatti, F, Grande, C, Gesmundo, I, Córdoba-Chacón, J, Bergandi, L, Settanni, F, Togliatto, G, Volante, M, Garetto, S, Annunziata, M, Chanclón, B, Gargantini, E, Rocchietto, S, Matera, L, Datta, G, Morino, M, Brizzi, MF, Ong, H, Camussi, G, Castaño, JP, Papotti, M & Ghigo, E 2012, 'Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation', FASEB Journal, vol. 26, no. 8, pp. 3393-3411. https://doi.org/10.1096/fj.11-201343
Granata, Riccarda ; Gallo, Davide ; Luque, Raul M. ; Baragli, Alessandra ; Scarlatti, Francesca ; Grande, Cristina ; Gesmundo, Iacopo ; Córdoba-Chacón, Jose ; Bergandi, Loredana ; Settanni, Fabio ; Togliatto, Gabriele ; Volante, Marco ; Garetto, Stefano ; Annunziata, Marta ; Chanclón, Belén ; Gargantini, Eleonora ; Rocchietto, Stefano ; Matera, Lina ; Datta, Giacomo ; Morino, Mario ; Brizzi, Maria Felice ; Ong, Huy ; Camussi, Giovanni ; Castaño, Justo P. ; Papotti, Mauro ; Ghigo, Ezio. / Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. In: FASEB Journal. 2012 ; Vol. 26, No. 8. pp. 3393-3411.
@article{79fdd16e5f2d4beb8f72070bd0a2bf5e,
title = "Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation",
abstract = "The metabolic actions of the ghrelin gene-derived peptide obestatin are still unclear. We investigated obestatin effects in vitro, on adipocyte function, and in vivo, on insulin resistance and inflammation in mice fed a high-fat diet (HFD). Obestatin effects on apoptosis, differentiation, lipolysis, and glucose uptake were determined in vitro in mouse 3T3-L1 and in human subcutaneous (hSC) and omental (hOM) adipocytes. In vivo, the influence of obestatin on glucose metabolism was assessed in mice fed an HFD for 8 wk. 3T3-L1, hSC, and hOM preadipocytes and adipocytes secreted obestatin and showed specific binding for the hormone. Obestatin prevented apoptosis in 3T3-L1 preadipocytes by increasing phosphoinositide 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK)1/2 signaling. In both mice and human adipocytes, obestatin inhibited isoproterenol-induced lipolysis, promoted AMP-activated protein kinase phosphorylation, induced adiponectin, and reduced leptin secretion. Obestatin also enhanced glucose uptake in either the absence or presence of insulin, promoted GLUT4 translocation, and increased Akt phosphorylation and sirtuin 1 (SIRT1) protein expression. Inhibition of SIRT1 by small interfering RNA reduced obestatin-induced glucose uptake. In HFD-fed mice, obestatin reduced insulin resistance, increased insulin secretion from pancreatic islets, and reduced adipocyte apoptosis and inflammation in metabolic tissues. These results provide evidence of a novel role for obestatin in adipocyte function and glucose metabolism and suggest potential therapeutic perspectives in insulin resistance and metabolic dysfunctions.",
keywords = "Glucose uptake, High-fat diet, Lipolysis, PI3K/Akt and AMP-activated protein kinase, Sirtuin 1",
author = "Riccarda Granata and Davide Gallo and Luque, {Raul M.} and Alessandra Baragli and Francesca Scarlatti and Cristina Grande and Iacopo Gesmundo and Jose C{\'o}rdoba-Chac{\'o}n and Loredana Bergandi and Fabio Settanni and Gabriele Togliatto and Marco Volante and Stefano Garetto and Marta Annunziata and Bel{\'e}n Chancl{\'o}n and Eleonora Gargantini and Stefano Rocchietto and Lina Matera and Giacomo Datta and Mario Morino and Brizzi, {Maria Felice} and Huy Ong and Giovanni Camussi and Casta{\~n}o, {Justo P.} and Mauro Papotti and Ezio Ghigo",
year = "2012",
month = "8",
doi = "10.1096/fj.11-201343",
language = "English",
volume = "26",
pages = "3393--3411",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "8",

}

TY - JOUR

T1 - Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation

AU - Granata, Riccarda

AU - Gallo, Davide

AU - Luque, Raul M.

AU - Baragli, Alessandra

AU - Scarlatti, Francesca

AU - Grande, Cristina

AU - Gesmundo, Iacopo

AU - Córdoba-Chacón, Jose

AU - Bergandi, Loredana

AU - Settanni, Fabio

AU - Togliatto, Gabriele

AU - Volante, Marco

AU - Garetto, Stefano

AU - Annunziata, Marta

AU - Chanclón, Belén

AU - Gargantini, Eleonora

AU - Rocchietto, Stefano

AU - Matera, Lina

AU - Datta, Giacomo

AU - Morino, Mario

AU - Brizzi, Maria Felice

AU - Ong, Huy

AU - Camussi, Giovanni

AU - Castaño, Justo P.

AU - Papotti, Mauro

AU - Ghigo, Ezio

PY - 2012/8

Y1 - 2012/8

N2 - The metabolic actions of the ghrelin gene-derived peptide obestatin are still unclear. We investigated obestatin effects in vitro, on adipocyte function, and in vivo, on insulin resistance and inflammation in mice fed a high-fat diet (HFD). Obestatin effects on apoptosis, differentiation, lipolysis, and glucose uptake were determined in vitro in mouse 3T3-L1 and in human subcutaneous (hSC) and omental (hOM) adipocytes. In vivo, the influence of obestatin on glucose metabolism was assessed in mice fed an HFD for 8 wk. 3T3-L1, hSC, and hOM preadipocytes and adipocytes secreted obestatin and showed specific binding for the hormone. Obestatin prevented apoptosis in 3T3-L1 preadipocytes by increasing phosphoinositide 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK)1/2 signaling. In both mice and human adipocytes, obestatin inhibited isoproterenol-induced lipolysis, promoted AMP-activated protein kinase phosphorylation, induced adiponectin, and reduced leptin secretion. Obestatin also enhanced glucose uptake in either the absence or presence of insulin, promoted GLUT4 translocation, and increased Akt phosphorylation and sirtuin 1 (SIRT1) protein expression. Inhibition of SIRT1 by small interfering RNA reduced obestatin-induced glucose uptake. In HFD-fed mice, obestatin reduced insulin resistance, increased insulin secretion from pancreatic islets, and reduced adipocyte apoptosis and inflammation in metabolic tissues. These results provide evidence of a novel role for obestatin in adipocyte function and glucose metabolism and suggest potential therapeutic perspectives in insulin resistance and metabolic dysfunctions.

AB - The metabolic actions of the ghrelin gene-derived peptide obestatin are still unclear. We investigated obestatin effects in vitro, on adipocyte function, and in vivo, on insulin resistance and inflammation in mice fed a high-fat diet (HFD). Obestatin effects on apoptosis, differentiation, lipolysis, and glucose uptake were determined in vitro in mouse 3T3-L1 and in human subcutaneous (hSC) and omental (hOM) adipocytes. In vivo, the influence of obestatin on glucose metabolism was assessed in mice fed an HFD for 8 wk. 3T3-L1, hSC, and hOM preadipocytes and adipocytes secreted obestatin and showed specific binding for the hormone. Obestatin prevented apoptosis in 3T3-L1 preadipocytes by increasing phosphoinositide 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK)1/2 signaling. In both mice and human adipocytes, obestatin inhibited isoproterenol-induced lipolysis, promoted AMP-activated protein kinase phosphorylation, induced adiponectin, and reduced leptin secretion. Obestatin also enhanced glucose uptake in either the absence or presence of insulin, promoted GLUT4 translocation, and increased Akt phosphorylation and sirtuin 1 (SIRT1) protein expression. Inhibition of SIRT1 by small interfering RNA reduced obestatin-induced glucose uptake. In HFD-fed mice, obestatin reduced insulin resistance, increased insulin secretion from pancreatic islets, and reduced adipocyte apoptosis and inflammation in metabolic tissues. These results provide evidence of a novel role for obestatin in adipocyte function and glucose metabolism and suggest potential therapeutic perspectives in insulin resistance and metabolic dysfunctions.

KW - Glucose uptake

KW - High-fat diet

KW - Lipolysis

KW - PI3K/Akt and AMP-activated protein kinase

KW - Sirtuin 1

UR - http://www.scopus.com/inward/record.url?scp=84864768395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864768395&partnerID=8YFLogxK

U2 - 10.1096/fj.11-201343

DO - 10.1096/fj.11-201343

M3 - Article

C2 - 22601779

AN - SCOPUS:84864768395

VL - 26

SP - 3393

EP - 3411

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 8

ER -